Read the press release here.
Shaw Scalpel
Hemostatix, a local medical device company, acquired by Michigan-based C2Dx
March 15, 2022
About a year and a half ago, Hemostatix Medical Technologies, a Bartlett-based company, was in talks with a big medical device company regarding an acquisition. The larger, undisclosed company was interested in Hemostatix’s intellectual property — a unique thermal scalpel that seals blood vessels as they are incised, effectively enabling cutting and coagulating at the
Shaw scalpel in revision Cochlear implant surgery
March 13, 2022
Shaw scalpel in revision Cochlear implant surgery Authors Thomas J. Roland, Andrew J. Fishman, Susan B. Waltzman, Noel L. Cohen
C2Dx Announces the Acquisition of Hemostatix and its Thermal Scalpel System
March 9, 2022
KALAMAZOO, Mich., March 8, 2022 /PRNewswire/ — C2Dx, a privately held medical device company, announced its acquisition of Hemostatix Medical Technologies LLC (Hemostatix) effective on January 1, 2022. This latest expansion aligns with C2Dx’s strategy to invest in and refine the delivery of valuable niche products to propel their growth and accessibility worldwide. The acquisition
2021 Newsmaker: Kevin McLeod
January 21, 2022
Kalamazoo-based medical device startup C2Dx was founded by Kevin McLeod and Ann Arbor-based growth capital firm Plymouth Growth in 2019 to invest in and refine the delivery of “valuable niche products” to propel its growth. And that’s exactly what happened in 2021. C2Dx’s second product acquisition occurred early last year when it purchased Stryker’s T/Pump
Shaw scalpel for breast mastectomy in a pacemaker implanted patient
January 13, 2022
Shaw scalpel for breast mastectomy in a pacemaker implanted patient Authors: Joho Tokumine; Kazuhiro Sugahara; Tomoaki Matsuyama; Kenichi Nitta; Tatsuya Fuchigami; Takahiko Miyaguni